reta vs semaglutide Acute and chronic effects of retatrutide, and long‐acting Retatrutide vs Semaglutide – Comparison

**Cardiovascular Diseases**: Semaglutide, Ozempics active ingredient, has been shown to cause pulse acceleration which can potentially lead to heart disease in the long run

(Disclaimer: This information is for education

Editors Note: Wadden has received grants from Novo Nordisk, as well as consulting fees from Novo Nordisk, advisory board service fees from Weight Watchers, and grant support from Eli Lilly

Oral Wegovy / Oral Semaglutide FAQs Considering a needle-free GLP-1 option

Trial 2 Results at Week 26 in a Trial of RYBELSUS Compared to Empagliflozin in Adult Patients with Type 2 Diabetes Mellitus in Combination with Metformin a The intent-to-treat population includes all randomized patients